FFM
Fairmount Funds Management Portfolio holdings
AUM
$772M
This Quarter Return
-13.78%
1 Year Return
+35.05%
3 Year Return
+1,168.51%
5 Year Return
+1,432.11%
10 Year Return
–
AUM
$237M
AUM Growth
+$237M
(-15%)
Cap. Flow
+$16.6M
Cap. Flow
% of AUM
6.99%
Top 10 Holdings %
Top 10 Hldgs %
74.51%
Holding
22
New
4
Increased
7
Reduced
5
Closed
1
Top Buys
| 1 |
Instil Bio
TIL
|
$13.8M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$8.29M |
| 3 |
Keros Therapeutics
KROS
|
$6.73M |
| 4 |
Seres Therapeutics
MCRB
|
$1.98M |
| 5 |
Axsome Therapeutics
AXSM
|
$1.78M |
Top Sells
| 1 |
Karyopharm Therapeutics
KPTI
|
$10.9M |
| 2 |
Amicus Therapeutics
FOLD
|
$5.2M |
| 3 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$1.66M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$1.63M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$464K |
Sector Composition
| 1 | Healthcare | 94.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Insmed
INSM
$28.8B
| $32.8M | 13.81% | 961,797 | – | – |
|
|
ZGNX
2
DELISTED
Zogenix, Inc.
ZGNX
| $27.4M | 11.56% | 1,405,259 +424,614 | +43% | +$8.29M |
|
3
Iovance Biotherapeutics
IOVA
$807M
| $17.9M | 7.55% | 565,890 | – | – |
|
|
ALLK
4
DELISTED
Allakos
ALLK
| $16.9M | 7.14% | 147,662 | – | – |
|
|
5
Axsome Therapeutics
AXSM
$6.05B
| $14.2M | 6% | 251,598 +31,500 | +14% | +$1.78M |
|
|
TRIL
6
DELISTED
Trillium Therapeutics Inc.
TRIL
| $14.2M | 5.99% | 1,323,181 -155,000 | -10% | -$1.66M |
|
7
argenx
ARGX
$43.6B
| $14.2M | 5.97% | 51,450 +1,500 | +3% | +$413K |
|
|
8
Instil Bio
TIL
$182M
| $13.8M | 5.81% | +550,000 | New | +$13.8M |
|
9
Cogent Biosciences
COGT
$1.69B
| $13.7M | 5.77% | 1,558,975 | – | – |
|
|
MRTX
10
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $11.6M | 4.9% | 67,800 +7,300 | +12% | +$1.25M |
|
|
11
Acadia Pharmaceuticals
ACAD
$4.38B
| $11.2M | 4.7% | 432,317 -18,000 | -4% | -$464K |
|
|
AMRN
12
Amarin Corp
AMRN
$311M
| $9.99M | 4.21% | 1,608,237 +100,000 | +7% | +$621K |
|
13
Enanta Pharmaceuticals
ENTA
$180M
| $8.44M | 3.56% | 171,147 +20,714 | +14% | +$1.02M |
|
|
14
Amicus Therapeutics
FOLD
$2.34B
| $7.8M | 3.29% | 788,980 -526,415 | -40% | -$5.2M |
|
|
15
Seres Therapeutics
MCRB
$166M
| $7.27M | 3.06% | 353,016 +96,000 | +37% | +$1.98M |
|
|
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $7.13M | 3.01% | 175,000 -40,000 | -19% | -$1.63M |
|
|
17
Keros Therapeutics
KROS
$618M
| $6.73M | 2.84% | +109,333 | New | +$6.73M |
|
|
VRNA
18
Verona Pharma
VRNA
$9.16B
| $702K | 0.3% | 83,944 -16,056 | -16% | -$134K |
|
19
Viridian Therapeutics
VRDN
$1.5B
| $581K | 0.24% | 35,092 | – | – |
|
|
PNT
20
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $526K | 0.22% | +50,000 | New | +$526K |
|
21
Astria Therapeutics
ATXS
$349M
| $154K | 0.06% | +53,166 | New | +$154K |
|
|
22
Karyopharm Therapeutics
KPTI
$61.7M
| – | – | -702,351 | Closed | -$10.9M |
|